An analysis of the aberrant methylation of the RNF219 gene in the blood plasma of patients allowed distinguishing PCa patients from BPH patients with a sensitivity of 61% and a specificity of 71% [54]; the good potential diagnostic properties of the KIAA1539 gene were also demonstrated in [54]. The gene discussed is ATOSB; the disease is benign prostatic hyperplasia.